Alzheimer'S Disease Clinical Trials in Columbia, SC

Alzheimer'S Disease Clinical Trials in Columbia, SC

View the best 10 alzheimer's disease medical studies in Columbia, South Carolina. Access promising new therapies by applying to a Columbia-based Alzheimer'S Disease clinical trial.

Top rated alzheimer's disease clinical trials in Columbia, South Carolina

Here are the top 7 medical studies for alzheimer's disease in Columbia, South Carolina

Image of Valley Clinical Trials, Inc. in Covina, United States.

Donanemab

Monoclonal Antibodies

Verified
Recruiting1 awardPhase 3
This trial will test a new drug, donanemab, for safety and effectiveness in people with early Alzheimer's disease.
Image of Brain Matters Research in Delray Beach, United States.

Sensory Stimulation System (GS120) - Active +1 More

Behavioural Intervention

Verified
Recruiting0 awards1 criteria
This trial tests a daily sensory stimulation system to help improve daily activities in people with Alzheimer's. 345 people will be studied for 12 months. Effects will be measured using ADCS-ADL and MMSE tests.
Image of Clinical Research Site in Peoria, United States.

AXS-05 +1 More

NMDA receptor antagonist

Verified
Recruiting1 awardPhase 3
This trial is studying whether a new drug, AXS-05, is effective and safe for treating people with Alzheimer's disease who have agitation.
Image of JEM Research Institute in Atlantis, United States.

CT1812

Behavioural Intervention

Recruiting0 awardsPhase 2
This trial is testing a new drug for Alzheimer's Disease. The study will last 36 weeks and will compare the new drug to a placebo.
Image of Linfritz Research Institute Inc. in Coral Gables, United States.

Piromelatine 20 mg +1 More

Melatonin Receptor Agonist

Recruiting0 awardsPhase 2 & 3
This trialtests if a drug can help improve mild dementia in Alzheimer's patients who lack a certain gene.
Image of ATP Clinical Research, Inc. in Costa Mesa, United States.

Masupirdine

Behavioural Intervention

Recruiting1 awardPhase 3
This trial will compare the effects of masupirdine vs. placebo on agitation in people with Alzheimer's Disease.
Image of ARS- Neurology and Neurodiagnostics of Alabama in Hoover, United States.

Donanemab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is studying how safe and effective donanemab is in treating early Alzheimer's disease.

Popular filter options for alzheimer's-disease columbia trials

Phase 3 Clinical Trials

View 21 phase 3 medical studies.

View More Alzheimer's-disease Columbia Trials

See another 9 medical studies focused on alzheimer's-disease columbia.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.